ARTICLE | Company News
Alizyme, Katholieke Universiteit Leuven deal
March 13, 2000 8:00 AM UTC
AZM obtained an exclusive global license from the university to the manufacturing process for AZM’s ATL-101 to treat cancer therapy-associated mucositis. AZM will pay the university a license fee and ...